BioXcel Therapeutics Inc

Biopharmaceutical company developing therapies for neuropsychiatric and neurological disorders using artificial intelligence.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

• Could a dissolving film calm agitated teens? new trial begins Results expected Jul 2027 (estimated)